<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">sibmed</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский научный медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Сибирский научный медицинский журнал</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-2512</issn><issn pub-type="epub">2410-2520</issn><publisher><publisher-name>ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18699/SSMJ20240506</article-id><article-id custom-type="elpub" pub-id-type="custom">sibmed-1702</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Роль внеклеточной АТФ в регуляции функциональной активности клеток</article-title><trans-title-group xml:lang="en"><trans-title>The role of extracellular ATP in regulating the functional activity of cells</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6219-5964</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Патракеева</surname><given-names>В. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Patrakeeva</surname><given-names>V. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Патракеева Вероника Павловна, к.б.н.</p><p>163065, г. Архангельск, пр. Никольский, 20</p></bio><bio xml:lang="en"><p>Veronika P. Patrakeeva, candidate of biological sciences</p><p>163065 Arkhangelsk, Nikolsky ave., 20</p></bio><email xlink:type="simple">patrakeewa.veronika@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Институт физиологии природных адаптаций ФИЦ комплексного изучения Арктики им. академика Н.П. Лаверова УроРАН<country>Россия</country></aff><aff xml:lang="en">Institute of Physiology of Natural Adaptations of N. Laverov Federal Center for Integrated Arctic Research of UrB RAS<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>30</day><month>10</month><year>2024</year></pub-date><volume>44</volume><issue>5</issue><fpage>53</fpage><lpage>60</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Патракеева В.П., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Патракеева В.П.</copyright-holder><copyright-holder xml:lang="en">Patrakeeva V.P.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://sibmed.elpub.ru/jour/article/view/1702">https://sibmed.elpub.ru/jour/article/view/1702</self-uri><abstract><p>Выполнены поиск и акализ научных статей, представленных в базах данных PubMed, ScienceDirect, Elsevier, eLibrary за 2000–2024 гг. Критерием отбора служило наличие в статьях информации о концентрации внеклеточной АТФ в нормальных и патологических тканях, механизмах пуринергической регуляции функционирования клеток, экспрессии на клетках эктонуклеотидаз CD73 и CD39, регулирующих катаболизм провоспалительной внеклеточной АТФ до иммуносупрессивного аденозина. Представлены современные данные о роли внеклеточной АТФ в регуляции функционирования клеток в норме и при патологии, при воспалении, формировании клеточного и гуморального иммунного ответа, а также об изучении механизмов пуринергической передачи сигналов от внеклеточной АТФ при разработке таргетных лекарственных препаратов при различных заболеваниях, включая новообразования, нейродегенеративные и аутоиммунные патологии.</p></abstract><trans-abstract xml:lang="en"><p>A search and analysis of scientific articles presented in the databases PubMed, ScienceDirect, Elsevier, eLibrary for 2000–2024 was carried out. The selection criterion was the presence in the articles of information on the concentration of extracellular ATP in normal and pathological tissues, the mechanisms of purinergic regulation of cell functioning, and the expression of CD73 and CD39 ectonucleotidases on cells, which regulate proinflammatory extracellular ATP catabolism to immunosuppressive adenosine. Modern data are presented on the role of extracellular ATP in the regulation of cell functioning under normal and pathological conditions, during inflammation and the formation of cellular and humoral immune responses, as well as on the study of the mechanisms of purinergic signaling from extracellular ATP in the development of targeted drugs for various diseases, including neoplasms, neurodegenerative and autoimmune pathologies.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>внеклеточная АТФ</kwd><kwd>аденозин</kwd><kwd>воспаление</kwd><kwd>пуринорецепторы</kwd><kwd>эктонуклеотидазы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>extracellular ATP</kwd><kwd>adenosine</kwd><kwd>inflammation</kwd><kwd>purinoreceptors</kwd><kwd>ectonucleotidases</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Работа выполнена в рамках программы фундаментальных научных исследований по теме лаборатории экологической иммунологии Института физиологии природных адаптаций ФГБУН ФИЦ комплексного изучения Арктики им. академика Н.П. Лаверова УроРАН, № гос. регистрации 122011300377-5.</funding-statement></funding-group><funding-group xml:lang="en"><funding-statement>The study was performed within the Program of Fundamental Scientific Research on the topic of the environmental immunology laboratory, Institute of Physiology of Natural Adaptations of N. Laverov Federal Center for Integrated Arctic Research, Ural Branch of the Russian Academy of Sciences (project № 122011300377-5).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Eltzschig H.K., Sitkovsky M.V., Robson S.C. Purinergic signaling during inflammation. N. Engl. J. Med. 2012;367(24):2322–2333. doi: 10.1056/NEJMra1205750</mixed-citation><mixed-citation xml:lang="en">Eltzschig H.K., Sitkovsky M.V., Robson S.C. Purinergic signaling during inflammation. N. Engl. J. Med. 2012;367(24):2322–2333. doi: 10.1056/NEJMra1205750</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang L., Chen H.Y., He C.H., Xu H.B., Zhou Z.R., Wu M.S., Fodjo E.K., He Y., Hafez M.E., Qian R.C., Li D.W. Dual-modal apoptosis assay enabling dynamic visualization of ATP and reactive oxygen species in living cells. Anal. Chem. 2023;95(6):3507–3515. doi: 10.1021/acs.analchem.2c05671</mixed-citation><mixed-citation xml:lang="en">Jiang L., Chen H.Y., He C.H., Xu H.B., Zhou Z.R., Wu M.S., Fodjo E.K., He Y., Hafez M.E., Qian R.C., Li D.W. Dual-modal apoptosis assay enabling dynamic visualization of ATP and reactive oxygen species in living cells. Anal. Chem. 2023;95(6):3507–3515. doi: 10.1021/acs.analchem.2c05671</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hasuzawa N., Moriyama S., Moriyama Y., Nomura M. Physiopathological roles of vesicular nucleotide transporter (VNUT), an essential component for vesicular ATP release. Biochim. Biophys. Acta Biomembr. 2020;1862(12):183408. doi: 10.1016/j.bbamem.2020.183408</mixed-citation><mixed-citation xml:lang="en">Hasuzawa N., Moriyama S., Moriyama Y., Nomura M. Physiopathological roles of vesicular nucleotide transporter (VNUT), an essential component for vesicular ATP release. Biochim. Biophys. Acta Biomembr. 2020;1862(12):183408. doi: 10.1016/j.bbamem.2020.183408</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Moriyama Y., Hiasa M., Sakamoto S., Omote H., Nomura M. Vesicular nucleotide transporter (VNUT): appearance of an actress on the stage of purinergic signaling. Purinergic. Signalling. 2017;13(3):387–404. doi: 10.1007/s11302-017-9568-1</mixed-citation><mixed-citation xml:lang="en">Moriyama Y., Hiasa M., Sakamoto S., Omote H., Nomura M. Vesicular nucleotide transporter (VNUT): appearance of an actress on the stage of purinergic signaling. Purinergic. Signalling. 2017;13(3):387–404. doi: 10.1007/s11302-017-9568-1</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gorelik J., Zhang Y., Sanchez D., Shevchuk A., Frolenkov G., Lab M., Klenerman D., Edwards C., Korchev Y. Aldosterone acts via an ATP autocrine/ paracrine system: the Edelman ATP hypothesis revisited. Pro.c Natl. Acad. Sci. USA. 2005;102(42):15000–15005. doi: 10.1073/pnas.0507008102</mixed-citation><mixed-citation xml:lang="en">Gorelik J., Zhang Y., Sanchez D., Shevchuk A., Frolenkov G., Lab M., Klenerman D., Edwards C., Korchev Y. Aldosterone acts via an ATP autocrine/ paracrine system: the Edelman ATP hypothesis revisited. Pro.c Natl. Acad. Sci. USA. 2005;102(42):15000–15005. doi: 10.1073/pnas.0507008102</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ismaeel S., Qadri A. ATP release drives inflammation with lysophosphatidylcholine. Immunohorizons. 2021;5(4):219–233. doi: 10.4049/immunohorizons.2100023</mixed-citation><mixed-citation xml:lang="en">Ismaeel S., Qadri A. ATP release drives inflammation with lysophosphatidylcholine. Immunohorizons. 2021;5(4):219–233. doi: 10.4049/immunohorizons.2100023</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Seminario-Vidal L., Kreda S., Jones L., O’Neal W., Trejo J., Boucher R.C., Lazarowski E.R. Thrombin promotes release of ATP from lung epithelial cells through coordinated activation of Rhoand Ca2+-dependent signaling pathways. J. Biol. Chem. 2009;284(31):20638–20648. doi: 10.1074/jbc.M109.004762</mixed-citation><mixed-citation xml:lang="en">Seminario-Vidal L., Kreda S., Jones L., O’Neal W., Trejo J., Boucher R.C., Lazarowski E.R. Thrombin promotes release of ATP from lung epithelial cells through coordinated activation of Rhoand Ca2+-dependent signaling pathways. J. Biol. Chem. 2009;284(31):20638–20648. doi: 10.1074/jbc.M109.004762</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Moritz C.E., Teixeira B.C., Rockenbach L., Reischak-Oliveira A., Casali E.A., Battastini A.M. Altered extracellular ATP, ADP, and AMP hydrolysis in blood serum of sedentary individuals after an acute, aerobic, moderate exercise session. Mol. Cell. Biochem. 2017;426(1-2):55–63. doi: 10.1007/s11010-016-2880-1</mixed-citation><mixed-citation xml:lang="en">Moritz C.E., Teixeira B.C., Rockenbach L., Reischak-Oliveira A., Casali E.A., Battastini A.M. Altered extracellular ATP, ADP, and AMP hydrolysis in blood serum of sedentary individuals after an acute, aerobic, moderate exercise session. Mol. Cell. Biochem. 2017;426(1-2):55–63. doi: 10.1007/s11010-016-2880-1</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Сладкова Е.А. Влияние пуринергической сигнальной системы на свойства клеток крови человека при старении организма. Ж. мед.-биол. исслед. 2021;9(1):51–57. doi: 10.37482/2687-1491-Z043</mixed-citation><mixed-citation xml:lang="en">Sladkova E.A. Influence of the purinergic signaling system on the properties of human blood cells at ageing. Zhurnal mediko-biologicheskikh issledovaniy = Journal of Medical and Biological Research. 2021;9(1):51– 57. [In Russian]. doi: 10.37482/2687-1491-Z043</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Antonioli L., Pacher P., Vizi E.S., Hasko G. CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 2013;19(6):355–367. doi: 10.1016/j.mol-med.2013.03.005</mixed-citation><mixed-citation xml:lang="en">Antonioli L., Pacher P., Vizi E.S., Hasko G. CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 2013;19(6):355–367. doi: 10.1016/j.mol-med.2013.03.005</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sperber H.S., Raymond K.A., Bouzidi M.S., Ma T., Valdebenito S., Eugenin E.A., Roan N.R., Deeks S.G., Winning S., Fandrey J., Schwarzer R., Pillai S. The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency. Сell Rep. 2023;42(11):113285. doi: 10.1016/j.cel-rep.2023.113285</mixed-citation><mixed-citation xml:lang="en">Sperber H.S., Raymond K.A., Bouzidi M.S., Ma T., Valdebenito S., Eugenin E.A., Roan N.R., Deeks S.G., Winning S., Fandrey J., Schwarzer R., Pillai S. The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency. Сell Rep. 2023;42(11):113285. doi: 10.1016/j.cel-rep.2023.113285</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kobayashi D., Umemoto E., Miyasaka M. The role of extracellular ATP in homeostatic immune cell migration. Curr. Opin Pharmacol. 2023;68:102331. doi: 10.1016/j.coph.2022.102331</mixed-citation><mixed-citation xml:lang="en">Kobayashi D., Umemoto E., Miyasaka M. The role of extracellular ATP in homeostatic immune cell migration. Curr. Opin Pharmacol. 2023;68:102331. doi: 10.1016/j.coph.2022.102331</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ledderose C., Bromberger S., Slubowski C.J., Sueyoshi K., Aytan D., Shen Y., Junger W.G. The purinergic receptor P2Y11 choreographs the polariza-tion, mitochondrial metabolism, and migration of T lymphocytes. Sci. Signal. 2020;13(651):eaba3300. doi: 10.1126/scisignal.aba3300</mixed-citation><mixed-citation xml:lang="en">Ledderose C., Bromberger S., Slubowski C.J., Sueyoshi K., Aytan D., Shen Y., Junger W.G. The purinergic receptor P2Y11 choreographs the polariza-tion, mitochondrial metabolism, and migration of T lymphocytes. Sci. Signal. 2020;13(651):eaba3300. doi: 10.1126/scisignal.aba3300</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ledderose C., Liu K., Kondo Y., Slubowski C.J., Dertnig T., Denicoló S., Arbab M., Hubner J., Konrad K., Fakhari M., … Junger W.G. Purinergic P2X4 receptors and mitochondrial ATP production regulate T cell migration. J. Clin. Invest. 2018;128(8): 3583–3594. doi: 10.1172/JCI120972</mixed-citation><mixed-citation xml:lang="en">Ledderose C., Liu K., Kondo Y., Slubowski C.J., Dertnig T., Denicoló S., Arbab M., Hubner J., Konrad K., Fakhari M., … Junger W.G. Purinergic P2X4 receptors and mitochondrial ATP production regulate T cell migration. J. Clin. Invest. 2018;128(8): 3583–3594. doi: 10.1172/JCI120972</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Gurusamy M., Tischner D., Shao J., Klatt S., Zukunft S., Bonnavion R., Günther S., Siebenbrodt K., Kestner R.I., Kuhlmann T., … Wettschureck N. G-protein-coupled receptor P2Y10 facilitates chemokine-induced CD4 T cell migration through autocrine/paracrine mediators. Nat. Commun. 2021;12(1):6798–6814. doi: 10.1038/s41467-021-26882-9</mixed-citation><mixed-citation xml:lang="en">Gurusamy M., Tischner D., Shao J., Klatt S., Zukunft S., Bonnavion R., Günther S., Siebenbrodt K., Kestner R.I., Kuhlmann T., … Wettschureck N. G-protein-coupled receptor P2Y10 facilitates chemokine-induced CD4 T cell migration through autocrine/paracrine mediators. Nat. Commun. 2021;12(1):6798–6814. doi: 10.1038/s41467-021-26882-9</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Burnstock G., Boeynaems J.M. Purinergic signalling and immune cells. Purinergic Signal. 2014;10(4):5229–5564. doi: 10.1007/s11302-014-9427-2</mixed-citation><mixed-citation xml:lang="en">Burnstock G., Boeynaems J.M. Purinergic signalling and immune cells. Purinergic Signal. 2014;10(4):5229–5564. doi: 10.1007/s11302-014-9427-2</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Junger W.G. Immune cell regulation by autocrine purinergic signaling. Nat. Rev. Immunol. 2011;11(3):201–212. doi: 10.1038/nri2938</mixed-citation><mixed-citation xml:lang="en">Junger W.G. Immune cell regulation by autocrine purinergic signaling. Nat. Rev. Immunol. 2011;11(3):201–212. doi: 10.1038/nri2938</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ledderose C., Junger W.G. Mitochondria synergize with P2 receptors to regulate human T cell function. Front. Immunol. 2020;11:549889. doi: 10.3389/fimmu.2020.549889</mixed-citation><mixed-citation xml:lang="en">Ledderose C., Junger W.G. Mitochondria synergize with P2 receptors to regulate human T cell function. Front. Immunol. 2020;11:549889. doi: 10.3389/fimmu.2020.549889</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Quiroga J., Alarcón P., Manosalva C., Taubert A., Hermosilla C., Hidalgo M.A., Carretta M.D., Burgos R.A. Mitochondria-derived ATP participates in the formation of neutrophil extracellular traps induced by platelet-activating factor through purinergic signaling in cows. Dev. Comp. Immunol. 2020;113:103768. doi: 10.1016/j.dci.2020.103768</mixed-citation><mixed-citation xml:lang="en">Quiroga J., Alarcón P., Manosalva C., Taubert A., Hermosilla C., Hidalgo M.A., Carretta M.D., Burgos R.A. Mitochondria-derived ATP participates in the formation of neutrophil extracellular traps induced by platelet-activating factor through purinergic signaling in cows. Dev. Comp. Immunol. 2020;113:103768. doi: 10.1016/j.dci.2020.103768</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Adrover J.M., McDowell S.A.C., He X.Y., Quail D.F., Egeblad M. NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps. Cancer Cell. 2023;41(3):505–526. doi: 10.1016/j.ccell.2023.02.001</mixed-citation><mixed-citation xml:lang="en">Adrover J.M., McDowell S.A.C., He X.Y., Quail D.F., Egeblad M. NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps. Cancer Cell. 2023;41(3):505–526. doi: 10.1016/j.ccell.2023.02.001</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bastid J., Cottalorda-Regairaz A., Alberici G., Bonnefoy N., Eliaou J.F., Bensussan A. ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene. 2013;32(14):1743–1751. doi: 10.1038/onc.2012.269</mixed-citation><mixed-citation xml:lang="en">Bastid J., Cottalorda-Regairaz A., Alberici G., Bonnefoy N., Eliaou J.F., Bensussan A. ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene. 2013;32(14):1743–1751. doi: 10.1038/onc.2012.269</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Nikolova M., Carriere M., Jenabian M.A., Limou S., Younas M., Kök A., Huë S., Seddiki N., Hulin A., Delaneau O., … Lévy Y. CD39/adenosine pathway is involved in AIDS progression. PLoS Pathog. 2011;7(7):e1002110. doi: 10.1371/journal.ppat.1002110</mixed-citation><mixed-citation xml:lang="en">Nikolova M., Carriere M., Jenabian M.A., Limou S., Younas M., Kök A., Huë S., Seddiki N., Hulin A., Delaneau O., … Lévy Y. CD39/adenosine pathway is involved in AIDS progression. PLoS Pathog. 2011;7(7):e1002110. doi: 10.1371/journal.ppat.1002110</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Guzman-Flores J.M., Cortez-Espinosa N., Cortés-Garcia J.D., Vargas-Morales J.M., Cataño-Cañizalez Y.G., Rodríguez-Rivera J.G., Portales-Perez D.P. Expression of CD73 and A2A receptors in cells from subjects with obesity and type 2 diabetes mellitus. Immunobiology. 2015;220(8):976–984. doi: 10.1016/j.imbio.2015.02.007</mixed-citation><mixed-citation xml:lang="en">Guzman-Flores J.M., Cortez-Espinosa N., Cortés-Garcia J.D., Vargas-Morales J.M., Cataño-Cañizalez Y.G., Rodríguez-Rivera J.G., Portales-Perez D.P. Expression of CD73 and A2A receptors in cells from subjects with obesity and type 2 diabetes mellitus. Immunobiology. 2015;220(8):976–984. doi: 10.1016/j.imbio.2015.02.007</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Радыгина Т.В., Купцова Д.Г., Петричук С.В., Семикина Е.Л., Фисенко А.П. Экспрессия эктонуклеотидаз CD39 и CD73 в популяциях CD4+ лимфоцитов у условно здоровых детей. Рос. иммунол. ж. 2022; 25(3):283–290. doi: 10.46235/1028-7221-1155-EOC</mixed-citation><mixed-citation xml:lang="en">Radygina T.V., Kuptsova D.G., Petrichuk S.V., Semikina E.L., Fisenko A.P. Expression of CD39 and CD73 ectonucleotidases in CD4+ lymphocyte populations in healthy children. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology. 2022;25(3):283–290. [In Russian]. doi: 10.46235/1028-7221-1155-EOC</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Chiarella A.M., Ryu Y.K., Manji G.A., Rustgi A.K. Extracellular ATP and adenosine in cancer pathogenesis and treatment. Trends Cancer. 2021;7(8):731–750. doi: 10.1016/j.trecan.2021.04.008</mixed-citation><mixed-citation xml:lang="en">Chiarella A.M., Ryu Y.K., Manji G.A., Rustgi A.K. Extracellular ATP and adenosine in cancer pathogenesis and treatment. Trends Cancer. 2021;7(8):731–750. doi: 10.1016/j.trecan.2021.04.008</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Hu L.P., Zhang X.X., Jiang S.H., Tao L.Y., Li Q., Zhu L.L., Yang M.W., Huo Y.M., Jiang Y.S., Tian G.A., … Zhang Z.G. Targeting purinergic receptor P2Y2 prevents the growth of pancreatic ductal adenocarcinoma by inhibiting cancer cell glycolysis. Clin. Cancer Res. 2019;25(4):1318–1330. doi: 10.1158/1078-0432.CCR-18-2297</mixed-citation><mixed-citation xml:lang="en">Hu L.P., Zhang X.X., Jiang S.H., Tao L.Y., Li Q., Zhu L.L., Yang M.W., Huo Y.M., Jiang Y.S., Tian G.A., … Zhang Z.G. Targeting purinergic receptor P2Y2 prevents the growth of pancreatic ductal adenocarcinoma by inhibiting cancer cell glycolysis. Clin. Cancer Res. 2019;25(4):1318–1330. doi: 10.1158/1078-0432.CCR-18-2297</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Virgilio F. Di, Adinolfi E. Extracellular purines, purinergic receptors and tumor growth. Oncogene. 2017;36(3):293–303. doi: 10.1038/onc.2016.206</mixed-citation><mixed-citation xml:lang="en">Virgilio F. Di, Adinolfi E. Extracellular purines, purinergic receptors and tumor growth. Oncogene. 2017;36(3):293–303. doi: 10.1038/onc.2016.206</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">de Marchi E., Orioli E., Pegoraro A., Sangaletti S., Portararo P., Curti A., Colombo M.P., di Virgilio F., Adinolfi E. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment. Oncogene. 2019;38(19):3636–3650. doi: 10.1038/s41388-019-0684-y</mixed-citation><mixed-citation xml:lang="en">de Marchi E., Orioli E., Pegoraro A., Sangaletti S., Portararo P., Curti A., Colombo M.P., di Virgilio F., Adinolfi E. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment. Oncogene. 2019;38(19):3636–3650. doi: 10.1038/s41388-019-0684-y</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Kepp O., Bezu L., Yamazaki T., di Virgilio F., Smyth M.J., Kroemer G., Galluzzi L. ATP and cancer immunosurveillance. EMBO J. 2021;40(13):e108130. doi: 10.15252/embj.2021108130</mixed-citation><mixed-citation xml:lang="en">Kepp O., Bezu L., Yamazaki T., di Virgilio F., Smyth M.J., Kroemer G., Galluzzi L. ATP and cancer immunosurveillance. EMBO J. 2021;40(13):e108130. doi: 10.15252/embj.2021108130</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Pietrocola F., Pol J., Vacchelli E., Rao S., Enot D.P., Baracco E.E., Levesque S., Castoldi F., Jacquelot N., Yamazaki T., … Kroemer G. Caloric restriction mimetics enhance anticancer immunosurveillance. Cancer Cell. 2016;30(1):147–160. doi: 10.1016/j.ccell.2016.05.016</mixed-citation><mixed-citation xml:lang="en">Pietrocola F., Pol J., Vacchelli E., Rao S., Enot D.P., Baracco E.E., Levesque S., Castoldi F., Jacquelot N., Yamazaki T., … Kroemer G. Caloric restriction mimetics enhance anticancer immunosurveillance. Cancer Cell. 2016;30(1):147–160. doi: 10.1016/j.ccell.2016.05.016</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang Z.F., Wu W., Hu H.B., Li Z.Y., Zhong M., Zhang L. P2X7 receptor as the regulator of T-cell function in intestinal barrier disruption. World J. Gastroenterol. 2022;28(36):5265–5279. doi: 10.3748/wjg.v28.i36.5265</mixed-citation><mixed-citation xml:lang="en">Jiang Z.F., Wu W., Hu H.B., Li Z.Y., Zhong M., Zhang L. P2X7 receptor as the regulator of T-cell function in intestinal barrier disruption. World J. Gastroenterol. 2022;28(36):5265–5279. doi: 10.3748/wjg.v28.i36.5265</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Dixit A., Cheema H., George J., Iyer S., Dudeja V., Dawra R., Saluja A.K. Extracellular release of ATP promotes systemic inflammation during acute pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2019;317(4):G463–G475. doi: 10.1152/ajpgi.00395.2018</mixed-citation><mixed-citation xml:lang="en">Dixit A., Cheema H., George J., Iyer S., Dudeja V., Dawra R., Saluja A.K. Extracellular release of ATP promotes systemic inflammation during acute pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2019;317(4):G463–G475. doi: 10.1152/ajpgi.00395.2018</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Dwyer K.M., Kishore B.K., Robson S.C. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease. Nat. Rev. Nephrol. 2020;16(9):509–524. doi: 10.1038/s41581-020-0304-7</mixed-citation><mixed-citation xml:lang="en">Dwyer K.M., Kishore B.K., Robson S.C. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease. Nat. Rev. Nephrol. 2020;16(9):509–524. doi: 10.1038/s41581-020-0304-7</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Скоркина М.Ю., Шевченко Т.С., Феттер В.В., Черкашина О.В., Пальчиков М.Ю. Влияние внеклеточной молекулы АТФ на функциональные свойства плазмалеммы гранулоцитов. Гены и клетки. 2020;15(3):63–67. doi: 10.23868/202011010</mixed-citation><mixed-citation xml:lang="en">Skorkina M.Yu., Shevchenko T.S., Fetter V.V., Cherkashina O.V., Palchikov M.Yu. Extracellular ATP molecules effects the functional properties of granulocyte plasma membrane. Geny i kletki = Genes and Cells. 2020;15(3):63–67. [In Russian]. doi: 10.23868/202011010</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Орлов С.Н., Смаглий Л.В., Гусакова С.В., Рыдченко В.С., Бирулина Ю.Г., Байков А.Н., Васильев В.Н., Суханова Г.А., Федорова Т.С., Ласукова Т.В. Роль калиевой проводимости мембраны в механизмах действия внеклеточного АТФ на сократительную активность сосудистых гладкомышечных клеток. Бюл. сиб. мед. 2016;15(5):105–112. doi: 10.20538/1682-0363-2016-5-105-112.</mixed-citation><mixed-citation xml:lang="en">Orlov S.N., Smaglii L.V., Gusakova S.V., Rydchenko V.S., Birulina Iu.G., Baikov A.N., Vasilev V.N., Sukhanova G.A., Fedorova T.S., Lasukova T.V. Role of potassium conductance in mechanisms of extracellular ATP impact on the contractive activity of vascular smooth muscle cells. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2016;15(5):105–112. [In Russian]. doi: 10.20538/1682-0363-2016-5-105-112</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Сервули Е.А., Постовская А.М., Сапожников А.М., Шевченко М.А Динамика изменения концентраций внеклеточных форм АТФ и белка теплового шока 70 кДа (БТШ70) при индуцированном аллергическом воспалении дыхательных путей. Рос. иммун. ж. 2014;8(3):398– 401.</mixed-citation><mixed-citation xml:lang="en">Servuli E.A., Postovskaya A.M., Sapozhnikov A.M., Shevchenko M.A. Time-dependent variation of concentrations of extracellular ATP and heat shock protein 70 kda (HSP70) in induced allergic airway inflammation. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology. 2014;8(3):398–401. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Mori Y., Shiratsuchi N., Sato N., Chaya A., Tanimura N., Ishikawa S., Kato M., Kameda I., Kon S., Haraoka Y., Ishitani T., Fujita Y. Extracellular ATP facilitates cell extrusion from epithelial layers mediated by cell competition or apoptosis. Curr. Biol. 2022;32(10):2144–2159.e5. doi: 10.1016/j.cub.2022.03.057</mixed-citation><mixed-citation xml:lang="en">Mori Y., Shiratsuchi N., Sato N., Chaya A., Tanimura N., Ishikawa S., Kato M., Kameda I., Kon S., Haraoka Y., Ishitani T., Fujita Y. Extracellular ATP facilitates cell extrusion from epithelial layers mediated by cell competition or apoptosis. Curr. Biol. 2022;32(10):2144–2159.e5. doi: 10.1016/j.cub.2022.03.057</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">MacLeod A.S., Rudolph R., Corriden R., Ye I., Garijo O., Havran W.L. Skin-resident T cells sense ultraviolet radiation-induced injury and contribute to DNA repair. J. Immunol. 2014;192(12):5695–702. doi: 10.4049/jimmunol.1303297</mixed-citation><mixed-citation xml:lang="en">MacLeod A.S., Rudolph R., Corriden R., Ye I., Garijo O., Havran W.L. Skin-resident T cells sense ultraviolet radiation-induced injury and contribute to DNA repair. J. Immunol. 2014;192(12):5695–702. doi: 10.4049/jimmunol.1303297</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Lalo U., Bogdanov A., Pankratov Y. Ageand experience-related plasticity of ATP-mediated signaling in the neocortex. Front. Cell. Neurosci. 2019;13:242. doi: 10.3389/fncel.2019.00242</mixed-citation><mixed-citation xml:lang="en">Lalo U., Bogdanov A., Pankratov Y. Ageand experience-related plasticity of ATP-mediated signaling in the neocortex. Front. Cell. Neurosci. 2019;13:242. doi: 10.3389/fncel.2019.00242</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Gaff J., Estiasari R., Diafiri D., Halstrom S., Kamerman P., Price P. Neurocognitive outcomes in indonesians living with HIV are influenced by polymorphisms in the gene encoding purinergic P2X receptor 7. Brain Behav. Immun. Health. 2021;13:100220. doi: 10.1016/j.bbih.2021.100220</mixed-citation><mixed-citation xml:lang="en">Gaff J., Estiasari R., Diafiri D., Halstrom S., Kamerman P., Price P. Neurocognitive outcomes in indonesians living with HIV are influenced by polymorphisms in the gene encoding purinergic P2X receptor 7. Brain Behav. Immun. Health. 2021;13:100220. doi: 10.1016/j.bbih.2021.100220</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Soare A.Y., Freeman T.L., Min A.K., Malik H.S., Osota E.O., Swartz T.H. P2RX7 at the host-pathogen interface of infectious diseases. Microbiol. Mol. Biol. Rev. 2021;85(1):e00055-20. doi: 10.1128/MMBR.00055-20</mixed-citation><mixed-citation xml:lang="en">Soare A.Y., Freeman T.L., Min A.K., Malik H.S., Osota E.O., Swartz T.H. P2RX7 at the host-pathogen interface of infectious diseases. Microbiol. Mol. Biol. Rev. 2021;85(1):e00055-20. doi: 10.1128/MMBR.00055-20</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Xu R., Yuan L.S., Gan Y.Q., Lu N., Li Y.P., Zhou Z.Y., Hu B., Wong T.S., He X.H., Zha Q.B., Ouyang D.Y. Extracellular ATP contributes to the reactive oxygen species burst and exaggerated mitochondrial damage in D-galactosamine and lipopolysaccharideinduced fulminant hepatitis. Int. Immunopharmacol. 2024;130:111680. doi: 10.1016/j.intimp.2024.111680</mixed-citation><mixed-citation xml:lang="en">Xu R., Yuan L.S., Gan Y.Q., Lu N., Li Y.P., Zhou Z.Y., Hu B., Wong T.S., He X.H., Zha Q.B., Ouyang D.Y. Extracellular ATP contributes to the reactive oxygen species burst and exaggerated mitochondrial damage in D-galactosamine and lipopolysaccharideinduced fulminant hepatitis. Int. Immunopharmacol. 2024;130:111680. doi: 10.1016/j.intimp.2024.111680</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Douguet L., Janho Dit Hreich S., Benzaquen J., Seguin L., Juhel T., Dezitter X. Duranton C., Ryffel B., Kanellopoulos J., Delarasse C., … Vouret-Craviari V. A small-molecule P2RX7 activator promotes antitumor immune responses and sensitizes lung tumor to immunotherapy. Nat. Commun. 2021;12(1):653. doi: 10.1038/s41467-021-20912-2</mixed-citation><mixed-citation xml:lang="en">Douguet L., Janho Dit Hreich S., Benzaquen J., Seguin L., Juhel T., Dezitter X. Duranton C., Ryffel B., Kanellopoulos J., Delarasse C., … Vouret-Craviari V. A small-molecule P2RX7 activator promotes antitumor immune responses and sensitizes lung tumor to immunotherapy. Nat. Commun. 2021;12(1):653. doi: 10.1038/s41467-021-20912-2</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Kamata-Sakurai M., Narita Y., Hori Y., Nemoto T., Uchikawa R., Honda M., Hironiwa N., Taniguchi K., Shida-Kawazoe M., Metsugi S., … Igawa T. Antibody to CD137 activated by extracellular adenosine triphosphate is tumor selective and broadly effective in vivo without systemic immune activation. Cancer Discov. 2021;11(1):158–175. doi: 10.1158/2159-8290.CD-20-0328</mixed-citation><mixed-citation xml:lang="en">Kamata-Sakurai M., Narita Y., Hori Y., Nemoto T., Uchikawa R., Honda M., Hironiwa N., Taniguchi K., Shida-Kawazoe M., Metsugi S., … Igawa T. Antibody to CD137 activated by extracellular adenosine triphosphate is tumor selective and broadly effective in vivo without systemic immune activation. Cancer Discov. 2021;11(1):158–175. doi: 10.1158/2159-8290.CD-20-0328</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Yoon M.J., Lee H.J., Kim J.H., Kim D.K. Extracellular ATP induces apoptotic signaling in human monocyte leukemic cells, HL-60 and F-36P. Arch. Pharm. Res. 2006;29(11):1032–1041. doi: 10.1007/BF02969288</mixed-citation><mixed-citation xml:lang="en">Yoon M.J., Lee H.J., Kim J.H., Kim D.K. Extracellular ATP induces apoptotic signaling in human monocyte leukemic cells, HL-60 and F-36P. Arch. Pharm. Res. 2006;29(11):1032–1041. doi: 10.1007/BF02969288</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Mimoto F., Tatsumi K., Shimizu S., Kadono S., Haraya K., Nagayasu M., Suzuki Y., Fujii E., Kamimura M., Hayasaka A., … Igawa T. Exploitation of elevated extracellular ATP to specifically direct antibody to tumor microenvironment. Cell Rep. 2020;33(12):108542. doi: 10.1016/j.celrep.2020.108542</mixed-citation><mixed-citation xml:lang="en">Mimoto F., Tatsumi K., Shimizu S., Kadono S., Haraya K., Nagayasu M., Suzuki Y., Fujii E., Kamimura M., Hayasaka A., … Igawa T. Exploitation of elevated extracellular ATP to specifically direct antibody to tumor microenvironment. Cell Rep. 2020;33(12):108542. doi: 10.1016/j.celrep.2020.108542</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Shi C., Chen M., Li X., Fu Y., Yang D., Wen T., Zhao W., Sun Y., Wang W., Lu C., … Quan G. ATPadenosine axis regulation combined with microneedle assisted photoimmunotherapy to boost the immunotherapy efficiency. J. Control. Release. 2024; 367:1–12. doi: 10.1016/j.jconrel.2024.01.035</mixed-citation><mixed-citation xml:lang="en">Shi C., Chen M., Li X., Fu Y., Yang D., Wen T., Zhao W., Sun Y., Wang W., Lu C., … Quan G. ATPadenosine axis regulation combined with microneedle assisted photoimmunotherapy to boost the immunotherapy efficiency. J. Control. Release. 2024; 367:1–12. doi: 10.1016/j.jconrel.2024.01.035</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Miras-Portugal M.T., Menéndez-Méndez A., Gómez-Villafuertes R., Ortega F., Delicado E.G., Pérez-Sen R., Gualix J. Physiopathological role of the vesicular nucleotide transporter (VNUT) in the central nervous system: relevance of the vesicular nucleotide release as a potential therapeutic target. Front. Cell. Neurosci. 2019;13:224. doi: 10.3389/fncel.2019.00224</mixed-citation><mixed-citation xml:lang="en">Miras-Portugal M.T., Menéndez-Méndez A., Gómez-Villafuertes R., Ortega F., Delicado E.G., Pérez-Sen R., Gualix J. Physiopathological role of the vesicular nucleotide transporter (VNUT) in the central nervous system: relevance of the vesicular nucleotide release as a potential therapeutic target. Front. Cell. Neurosci. 2019;13:224. doi: 10.3389/fncel.2019.00224</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Hasan D., Shono A., van Kalken C.K., van der Spek P.J., Krenning E.P., Kotani T. A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signaling. Purinergic Signal. 2022;18(1):13–59. doi: 10.1007/s11302-021-09814-6</mixed-citation><mixed-citation xml:lang="en">Hasan D., Shono A., van Kalken C.K., van der Spek P.J., Krenning E.P., Kotani T. A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signaling. Purinergic Signal. 2022;18(1):13–59. doi: 10.1007/s11302-021-09814-6</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Pacheco P.A.F., Faria R.X. The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target? Scand. J. Immunol. 2021;93(2):e12960. doi: 10.1111/sji.12960</mixed-citation><mixed-citation xml:lang="en">Pacheco P.A.F., Faria R.X. The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target? Scand. J. Immunol. 2021;93(2):e12960. doi: 10.1111/sji.12960</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Agteresch H.J., Dagnelie P.C., van der Gaast A., Stijnen T., Wilson J.H. Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer. J. Natl. Cancer Inst. 2000;92(4):321–328. doi: 10.1093/jnci/92.4.321</mixed-citation><mixed-citation xml:lang="en">Agteresch H.J., Dagnelie P.C., van der Gaast A., Stijnen T., Wilson J.H. Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer. J. Natl. Cancer Inst. 2000;92(4):321–328. doi: 10.1093/jnci/92.4.321</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Beijer S., Hupperets P.S., van den Borne B.E., Eussen S.R., van Henten A.M., van den Beukenvan Everdingen M., de Graeff A., Ambergen T.A., van den Brandt P.A., Dagnelie P.C. Effect of adenosine 5′-triphosphate infusions on the nutritional status and survival of preterminal cancer patients. Anticancer Drugs. 2009;20(7):625–633. doi: 10.1097/CAD.0b013e32832d4f22</mixed-citation><mixed-citation xml:lang="en">Beijer S., Hupperets P.S., van den Borne B.E., Eussen S.R., van Henten A.M., van den Beukenvan Everdingen M., de Graeff A., Ambergen T.A., van den Brandt P.A., Dagnelie P.C. Effect of adenosine 5′-triphosphate infusions on the nutritional status and survival of preterminal cancer patients. Anticancer Drugs. 2009;20(7):625–633. doi: 10.1097/CAD.0b013e32832d4f22</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Rapaport E., Salikhova A., Abraham E.H. Continuous intravenous infusion of ATP in humans yields large expansions of erythrocyte ATP pools but extracellular ATP pools are elevated only at the start followed by rapid declines. Purineric Signal. 2015;11(2):251– 262. doi: 10.1007/s11302-015-9450-y</mixed-citation><mixed-citation xml:lang="en">Rapaport E., Salikhova A., Abraham E.H. Continuous intravenous infusion of ATP in humans yields large expansions of erythrocyte ATP pools but extracellular ATP pools are elevated only at the start followed by rapid declines. Purineric Signal. 2015;11(2):251– 262. doi: 10.1007/s11302-015-9450-y</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Coolen E.J., Arts I.C., Bekers O., Vervaet C., Bast A., Dagnelie P.C. Oral bioavailability of ATP after prolonged administration. Br. J. Nutr. 2011;105(3):357– 366. doi: 10.1017/S0007114510003570</mixed-citation><mixed-citation xml:lang="en">Coolen E.J., Arts I.C., Bekers O., Vervaet C., Bast A., Dagnelie P.C. Oral bioavailability of ATP after prolonged administration. Br. J. Nutr. 2011;105(3):357– 366. doi: 10.1017/S0007114510003570</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Kichenin K., Seman M. Chronic oral administration of ATP modulates nucleoside transport and purine metabolism in rats. J. Pharmacol. Exp. Ther. 2000;294(1):126–133.</mixed-citation><mixed-citation xml:lang="en">Kichenin K., Seman M. Chronic oral administration of ATP modulates nucleoside transport and purine metabolism in rats. J. Pharmacol. Exp. Ther. 2000;294(1):126–133.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Kichenin K., Decollogne S., Angignard J., Seman M. Cardiovascular and pulmonary response to oral administration of ATP in rabbits. J. Appl. Physiol. 2000;88(6):1962–1968. doi: 10.1152/jappl.2000.88.6.1962</mixed-citation><mixed-citation xml:lang="en">Kichenin K., Decollogne S., Angignard J., Seman M. Cardiovascular and pulmonary response to oral administration of ATP in rabbits. J. Appl. Physiol. 2000;88(6):1962–1968. doi: 10.1152/jappl.2000.88.6.1962</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
